Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -23.23x as of the fiscal period ended Friday, June 30, 2023.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-23.23x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.24x
median of 361 covered companies
CURRENT VS SECTOR MEDIAN
-447.87%
vs the sector median at left
Artiva Biotherapeutics, Inc.
Market Cap
$340.28M
Interest Coverage Ratio
-23.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$342.72M
Interest Coverage Ratio
-0.37x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.39x
Market Cap
$337.38M
Interest Coverage Ratio
-10.12x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$352.72M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$353.30M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$326.11M
Interest Coverage Ratio
-85.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$354.62M
Interest Coverage Ratio
-26.33x
TTM Avg
2025.11x
3Y Avg
2025.11x
5Y Avg
2025.11x
Market Cap
$325.07M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$357.79M
Interest Coverage Ratio
-3.05x
TTM Avg
0.61x
3Y Avg
0.61x
5Y Avg
0.61x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | $340.28M | -23.23x | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $342.72M | -0.37x | 0.39x | 0.39x | 0.39x |
| ClearPoint Neuro, Inc. (CLPT)vs › | $337.38M | -10.12x | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $352.72M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Embecta Corp. (EMBC)vs › | $353.30M | 3.07x | 2.31x | 3.74x | 3.74x |
| Cabaletta Bio, Inc. (CABA)vs › | $326.11M | -85.95x | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $354.62M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
| C4 Therapeutics, Inc. (CCCC)vs › | $325.07M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $357.79M | -3.05x | 0.61x | 0.61x | 0.61x |
| CapsoVision, Inc. (CV)vs › | $322.44M | N/A | N/A | N/A | N/A |
Interest Coverage
-23.2x
Debt/Equity
0.03
Current Ratio
24.16
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-06-30 | -23.23x |
